These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 17591366)
1. Expression of estrogen receptor alpha and progesterone receptor in normal human breast epithelium. Umekita Y; Souda M; Ohi Y; Rai Y; Sagara Y; Sagara Y; Yoshida H In Vivo; 2007; 21(3):535-9. PubMed ID: 17591366 [TBL] [Abstract][Full Text] [Related]
2. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
3. Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression. Umekita Y; Souda M; Ohi Y; Sagara Y; Rai Y; Takahama T; Yoshida H Pathol Int; 2006 Aug; 56(8):423-7. PubMed ID: 16872435 [TBL] [Abstract][Full Text] [Related]
4. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry]. Masiuk M Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394 [TBL] [Abstract][Full Text] [Related]
5. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas. Muñoz-de-Toro M; Durando M; Beldoménico PM; Beldoménico HR; Kass L; García SR; Luque EH Breast Cancer Res; 2006; 8(4):R47. PubMed ID: 16859517 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer? Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124 [TBL] [Abstract][Full Text] [Related]
7. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
8. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Roger P; Sahla ME; Mäkelä S; Gustafsson JA; Baldet P; Rochefort H Cancer Res; 2001 Mar; 61(6):2537-41. PubMed ID: 11289127 [TBL] [Abstract][Full Text] [Related]
10. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124 [TBL] [Abstract][Full Text] [Related]
11. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005 [TBL] [Abstract][Full Text] [Related]
12. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors. Thorpe SM Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361 [TBL] [Abstract][Full Text] [Related]
14. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
15. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621 [TBL] [Abstract][Full Text] [Related]
16. CD109 expression in basal-like breast carcinoma. Hasegawa M; Moritani S; Murakumo Y; Sato T; Hagiwara S; Suzuki C; Mii S; Jijiwa M; Enomoto A; Asai N; Ichihara S; Takahashi M Pathol Int; 2008 May; 58(5):288-94. PubMed ID: 18429827 [TBL] [Abstract][Full Text] [Related]
17. Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma. van Velthuysen ML; Taal BG; van der Hoeven JJ; Peterse JL Histopathology; 2005 Feb; 46(2):153-7. PubMed ID: 15693887 [TBL] [Abstract][Full Text] [Related]
18. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues. Bozkurt KK; Kapucuoğlu N Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175 [TBL] [Abstract][Full Text] [Related]
19. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast. Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076 [TBL] [Abstract][Full Text] [Related]
20. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer. Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]